World | 2021-02-24 16:36:45 China is moving ahead with two more COVID-19 vaccines in the regulatory process, one from state-owned company Sinopharm and another from a private company CanSino. Both vaccines have submitted been to regulators for approval this week. CanSino said that Chinese regulators are reviewing its application for its COVID-19 vaccine, in a stock filing on Wednesday.…

This data comes from the ChinaPulse.com media intelligence and smart news insights platform.